Ingalls & Snyder’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,000
Closed -$37.9K – 494
2026
Q2
$33K Buy
+3,000
New +$18.4K ﹤0.01% 471

Other funds holding REPL

Ingalls & Snyder's REPL Position: Q3 2026 in Review

Ingalls & Snyder sold out of Replimune Group (REPL) in Q3 2026, closing a stake of 3,000 shares — an estimated $37.9K sold.

Ingalls & Snyder first reported a position in REPL in Q2 2026 and held it in 1 quarter. The position peaked at $33K in Q2 2026. 210 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Ingalls & Snyder reported no remaining Replimune Group position as of Q3 2026 after selling out during the quarter.
  • Ingalls & Snyder sold 3,000 Replimune Group shares in Q3 2026, an estimated $37.9K.
  • Ingalls & Snyder first reported a position in Replimune Group in Q2 2026 and held it in 1 quarter.
  • Ingalls & Snyder's Replimune Group position peaked at $33K in Q2 2026.
  • 210 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.